Prne
April 16th, 2009
CLEVELAND, Ohio - Simbionix, the world’s leading developer of medical simulation systems, today announced an agreement with Johnson & Johnson LLC for distribution of Simbionix’s simulators and related products.
Johnson & Johnson LLC, a subsidiary of Johnson & Johnson, operates in Russia, the Ukraine, and other CIS countries.
Johnson & Johnson LLC will have exclusive rights to distribute Simbionix’s line of advanced medical simulators in hospitals in Russia and the rest of the CIS.
“We are very excited to enter into this collaboration with Johnson & Johnson LLC to bring our advanced simulators into Russian hospitals, teaching facilities, and interventional clinics,” said Simbionix CEO Gary Zamler. “This agreement ushers in a new era of simulation-based interventional training for the CIS medical community and we are looking forward to a mutually beneficial relationship with all the countries covered by the agreement, as well as with Johnson & Johnson LLC.”
“In the last year, Simbionix has increased its distribution channels and its presence on the international market,” explains Mr. Doron Zilberman, Simbionix’s VP of International Sales. “We see Russia as one of the leading markets in the emerging medical world, and our agreement is a sign of Simbionix’s success in the international market …”
About Simbionix
Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.
Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures. Visit www.simbionix.com
Contact: Inbal Mazor VP Marketing Simbionix mailto:inbal@simbionix.com www.simbionix.com Tel: +972-8-9211177 ext. 222
Source: Simbionix Ltd.
Contact: Inbal Mazor, VP Marketing, Simbionix, mailto:inbal at simbionix.com, Tel: +972-8-9211177 ext. 222
Filed under Contracts, Health, Health Care / Hospitals, Investors, Pharmaceuticals | Tags: Cleveland, Ohio, Simbionix Ltd., United States of America | Comment Below
Related Press Releases Simbionix USA Corporation's Innovative Development Division Releases Two New Breakthrough TechnologiesSeptember 20th, 2009 CLEVELAND, Ohio - Simbionix USA Corporation, the world's leading developer of medical simulation systems, just released two new products: a new Laparoscopic Essential Tasks Module for its LAP Mentor(TM) and a breakthrough technology for patient-specific simulation based on actual patient data - the PROcedure Rehearsal Studio(TM). The new Laparoscopic Essential Tasks Module is an addition to the LAP Mentor's ever-expanding library of modules. More Safety Thanks to Focus on EssentialsSeptember 10th, 2009 BURSCHEID, Germany -
- Johnson Controls Presents New Head-Up Display With Vehicle-Independent Integration
Johnson Controls, one of the world's leading suppliers of automotive interior systems, electronics and batteries is providing a Head Medium Display for the new 5008 model, which is premiering at the International Motor Show (IAA), and the Peugeot 3008 model. This optional device displays key vehicle information such as speed and distance readings directly in the driver's primary field of vision, so there is no need for drivers to take their eyes off the road. Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity InvestmentJuly 1st, 2009 NEW BRUNSWICK, New Jersey and DUBLIN -
- First-in-Class Alzheimer's Treatments Expand Existing J&J Neuroscience Pipeline
- Johnson & Johnson Equity Investment Provides Financial Flexibility for Elan
Johnson & Johnson (NYSE: JNJ) and Elan Corporation plc (NYSE: ELN) today announced a definitive agreement whereby Johnson & Johnson will acquire substantially all of the assets and rights of Elan related to its Alzheimer's Immunotherapy Program (AIP Program), through a newly formed company. In addition, Johnson & Johnson, through its affiliate, will invest $1 billion in Elan in exchange for newly issued American Depositary Receipts (ADRs) of Elan which will represent 18.4% of Elan's outstanding ordinary shares. Simbionix Signs Agreement With the European Association for Endoscopic SurgeryJune 29th, 2009 PRAGUE - Prague Convention Center - Simbionix and the European Association for Endoscopic Surgery (EAES) have signed an agreement to collaborate on the development of training materials and assessment tools for a new Laparoscopic Skills Curriculum. Since its founding in 1990, the EAES has played a leading role in the promotion and dissemination of endoscopic surgery and allied interventional techniques throughout Europe. Today's Brands Are in Danger of 'Genericizing'June 11th, 2009 NEW YORK - JWT Examines a Key Marketing Challenge of the Great Recession
Marketers must evolve how they handle short-term selling tactics -- a primary focus of brand activity during this recession -- or they risk their brands becoming generic, according to the latest white paper from JWT, one of the largest advertising agencies in the world. The white paper, "The Genericizing of Brands," emerged out of JWT's research on consumer and brand response to the global recession in the first quarter of 2009. Simbionix and B-Line Medical(R) Announce Multi-Level AgreementMay 4th, 2009 CLEVELAND Ohio, and WASHINGTON DC - Simulation Technology Leader and the Leading Developer of Simulation-based Healthcare Training Platforms Form Cooperative Agreement
Simbionix USA Corporation and B-Line Medical, LLC, today announced a strategic agreement enabling the data integration of Simbionix Mentor(TM) simulation systems with B-Line Medical's SimCapture(R) product. The collaboration will combine Simbionix' unique data collected during a simulation session with video streams into the SimCapture system for debriefing, assessing and centralizing multiple types of simulated encounters. Nfocus Neuromedical Elects Eric P. Milledge Chairman of BoardApril 29th, 2009 PALO ALTO, California - Milledge brings proven experience, dynamic insights and strategic focus to neurovascular interventions developer. Nfocus Neuromedical Inc. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS CountriesApril 15th, 2009 CLEVELAND, Ohio - Simbionix, the world's leading developer of medical simulation systems, today announced an agreement with Johnson & Johnson LLC for distribution of Simbionix's simulators and related products. Johnson & Johnson, LLC operates in Russia, Ukraine and CIS countries and is one of the subsidiaries of Johnson & Johnson. Prizes of the Grand Prix MSOO Award Presented in MoscowMarch 16th, 2009 MOSCOW - During the 14th International Salon of Ophthalmologic Optics held at
Expocentre (Moscow) prizes were handed to the nominees of the Second National
Optical Award Grand Prix MSOO. In 2008 opticians and consumers of optical products got their
first opportunity to choose the aces of the aces. Simbionix Increases Product Offerings for OB/GYN PhysiciansMarch 10th, 2009 CLEVELAND and ZURICH, Switzerland - Simbionix and VirtaMed Have Joined Forces to Provide OB/GYN Surgeons
the Most Advanced Training System for Endoscopic Surgery
- The New VirtaMed HystSim(TM) Simulator Adds Hysteroscopy to Simbionix'
Impressive Line of Medical Simulation and eLearning Products
Simbionix, the world's leading developer of medical simulation systems,
and VirtaMed, a Swiss medical engineering company, announced today a global
collaboration agreement. Simbionix will exclusively distribute, market, and
provide service for the VirtaMed HystSim, an advanced virtual reality
hysteroscopy simulator.
Related News Bengals sign FB Jeremi Johnson, who sat out 2008 season with injuryApril 24th, 2009 Bengals sign FB Jeremi JohnsonCINCINNATI — The Cincinnati Bengals have signed fullback Jeremi Johnson, a regular for five seasons before sitting out last season with an injury. Terms were not released. Slumping Kelly Johnson held out of Braves' lineup for second straight game against CardinalsApril 30th, 2009 Johnson held out of Braves' lineup againATLANTA — Slumping second baseman Kelly Johnson was held out of the Atlanta Braves' starting lineup for the second straight day. Braves manager Bobby Cox gave Omar Infante his second straight start for Johnson, who is hitting .203, in Wednesday night's game against St. Tiger falters late again, leaving Johnson in the lead at Quail HollowMay 3rd, 2009 Johnson emerges with a 2-shot lead at Quail HollowCHARLOTTE, N.C. — Tiger Woods dropped out of the lead with late bogeys for the second straight day, leaving former Masters champion Zach Johnson with a two-shot advantage Saturday heading into the final round of the Quail Hollow Championship. Role of spearhead has left me exhausted: JohnsonDecember 31st, 2008 SYDNEY - In the absence of Brett Lee and Stuart Clarke, Mitchell Johnson has emerged as the spearhead of a depleted Australian bowling attack but the pacer admits his new role has left him 'exhausted'. For the third Test in Sydney Saturday, Johnson will lead the pace attack, despite the fact he made his debut last summer and has only 17 Tests under his belt. Elan says federal judge ruled it broke terms of Tysabri deal with Biogen IdecSeptember 4th, 2009 Elan says court rules against it in Biogen caseNEW YORK — Irish drugmaker Elan says a federal judge ruled it violated the terms of an agreement with Biogen Idec to market the multiple sclerosis treatment Tysabri when it struck a separate deal to collaborate with Johnson & Johnson. Elan Corp. PLC said in a statement late Thursday that it respects the court decision and plans to complete its deal with Johnson & Johnson while staying in compliance with its earlier deal with Biogen Idec Inc. Bob Marley keyboardist Wycliffe "Steely" Johnson dies in NY at 47; produced dancehall hitsSeptember 6th, 2009 Bob Marley keyboardist dies in NY at 47NEW YORK — Jamaican reggae producer Wycliffe "Steely" Johnson, a keyboardist for Bob Marley, has died in New York at age 47. Fellow producer Cleveland "Clevie" Browne says Johnson died Tuesday at Brookhaven Memorial Hospital on Long Island, following a heart attack. Elan sees Johnson & Johnson cut partnership deal value on amendment after contract breachSeptember 14th, 2009 Elan sees J&J cut deal value in contract amendmentNEW YORK — Elan Corp. said Monday Johnson & Johnson will reduce the value of a partnership deal under an amendment as part of a move meant to fix a contract breach with Biogen Idec Inc. Obama nominates son of SD Sen. Tim Johnson to be US attorneyJuly 11th, 2009 Obama picks SD senator's son as US attorneyWASHINGTON — President Barack Obama nominated Brendan Johnson, the 34-year-old son of Sen. Tim Johnson, D-S.D., on Friday to serve as U.S. Harden solid, Johnson has 3 RBIs to lead Chicago Cubs over Houston Astros 6-3May 8th, 2009 Harden pitches into 8th, Cubs beat Astros 6-3HOUSTON — Rich Harden pitched into the eighth inning and Reed Johnson hit a bases-loaded triple Wednesday night to lead the Chicago Cubs over the Houston Astros 6-3. Aramis Ramirez added a solo home run for the Cubs, who have won five of six. Sheila Johnson, BET co-founder and largely Democratic donor, backs GOP's McDonnell for Va. govJuly 20th, 2009 BET co-founder sides with Republican for Va. govRICHMOND, Va.
|
|